Fundamental dimension Equity attribute | BSYPeer $39.70▲+0.74% Cap $11.54BP/E 43.2x QuantScore51/100 | ADSKLeader $240.70▲+0.33% Cap $50.31BP/E 31.0x QuantScore69/100 | FLRPeer $44.05▲+1.45% Cap $5.89BP/E -3.7x QuantScore35/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
73/100 |
87/100 |
25/100 |
Valuation Multiples, PEG & DCF upside | 39/100 | 61/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 47/100 | 61/100 | 44/100 |
Growth Revenue / earnings growth & margins | 52/100 | 53/100 | 7/100 |
Sentiment Analyst ratings, targets & revisions | 44/100 | 82/100 | 63/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 43.2x | 31.0x | -3.7x |
Forward P/E (next FY) | 28.3x | 19.1x | 16.3x |
EV / EBITDA (TTM) | 26.4x | 21.6x | -112.2x |
Price / Sales | 7.2x | 6.5x | 0.4x |
Price / Free Cash Flow | 23.1x | 17.8x | -17.9x |
PEG ratio | 3.18 | 0.52 | 0.10 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 9 / 9 | 9 / 9 | 4 / 9 |
Altman Z-Score | 3.58 (Safe) | 4.06 (Safe) | 3.71 (Safe) |
Total debt / equity | 1.05 | 1.10 | 0.40 |
Quick ratio | 0.6x | 0.9x | 1.8x |
Interest coverage | 9.5x | 1073.0x | -8.5x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +11.0% | +17.5% | -5.0% |
Net income growth YoY | +18.3% | +1.1% | -102.4% |
Gross margin (TTM) | 81.8% | 91.2% | -0.8% |
Operating margin (FY) | 24.1% | 21.9% | -2.3% |
FCF margin (FY) | 34.6% | 33.4% | -2.8% |
5. Trailing price performancePrice change over period |
1M return | +24.5% | +10.9% | -13.0% |
3M return | +26.4% | +10.2% | -15.6% |
6M return | +18.7% | -0.5% | -8.7% |
Year to date | +4.0% | -18.7% | +11.2% |
1Y return | -23.3% | -21.8% | -10.0% |
3Y return | -21.0% | +16.8% | +29.8% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $34.85 -12.2% premium | $124.43 -48.3% premium | $8.07 -81.7% premium |
Wall Street consensus target | $41.67 +5.0% · range $40.00–$43.00 | $301.13 +25.1% · range $215.00–$341.00 | $62.33 +41.5% · range $50.00–$71.00 |
Consensus stance | 62% Buy31% Hold8% Sell | 75% Buy17% Hold8% Sell | 54% Buy46% Hold0% Sell |